Intrinsic Value of S&P & Nasdaq Contact Us

DaVita Inc. DVA NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
$360.50
+141.2%
Analyst Price Target
$168.67
+12.9%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

DaVita Inc. (DVA) has shown moderate revenue growth over the past 3 years, expanding from $11.6B to $13.6B (average +5.5%/yr). Net income reached $747M, reflecting modest earnings improvement at +1.7%/yr on average. The net profit margin is 5.5%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 27% (low), with a -2.3pp trend over the period. With a $10B market cap and MOAT composite score of 48/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (55/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 32-year history, the company was profitable in 30 of 32 years — an excellent long-term track record
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (48/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 59/100 with 2/7 criteria passed.

59/100
SG Score
View full scorecard →
VALUE
75/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $9.51
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
48/100
Score: 48/100
GM 27% (-2.3pp)
Proven by this page
~
GROWTH
55/100
Rev +5.5%/yr
NI +1.7%/yr
Proven by this page
~
INCOME
45/100
Margin 5.5%
$13.6B
Proven by this page
DaVita Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $13.64B$13.64B$12.82B$12.14B$11.61B
Gross Profit $4.21B$3.68B$4.22B$3.82B$3.4B
Gross Margin 30.9%27%32.9%31.5%29.3%
Operating Income $2.03B$2.01B$2.09B$1.6B$1.34B
Net Income $746.8M$746.8M$936.34M$691.54M$768.19M
Net Margin 5.5%5.5%7.3%5.7%6.6%
EPS (Diluted) $9.07$9.51$10.73$7.42$8.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message